The Pharmaceutical and Poisons Amendment Law no. 67 of 2019.

This Law, consisting of 12 articles and amending the 1959 version of the Pharmacy and Poisons Law and its subsequent versions, provides for the modernisation and adaptation of the pharmaceutical practice to the necessary reforms in view of the implementation of the General Health System and implements the Regulation (EC) No. 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. The following relevant terms are defined: disability; generic medicinal product; dosage of medicinal product; active substance; recipient; prescription execution; controlled drug; outpatient; recurring prescription; validating decree; non-prescription medicinal products; healthcare service; pharmaceutical product. The Law defines that pharmacists may execute prescriptions and sell or supply pharmaceutical products; specifies conditions for establish a hospital pharmacy in a hospital; prescribes conditions for the implementation of medical recipes, the supply of pharmaceutical products and active substances and excipients; details duties of pharmacists concerning prescription files, pharmaceutical products containing controlled drugs in accordance with the provisions of the World Health Organisation. The Law provides for a non-exhaustive list of information that medical prescription must include.